---
created: 2025-04-13
updated: 2025-04-13T10:53
id: I]+8{{6&}K
specialty: derm
specialty_id: 71
tags:
  - source/ak-original-decks::step-2::cheesy-dorian-(m3)
  - "source/ak-step1-v11:": 
  - theme/nbme::22
  - "source/ak-step1-v11:": 
  - source/ome-banner::clinical::09-dermatology::05-hyperpigmentation
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::15000-15999::15423
  - source/ak-step2-v11::!flag-these-cards::potential-duplicates
  - "source/ak-step2-v11::!shelf:": 
  - theme/cards-anking-skipped
  - "source/ak-step2-v11:": 
  - theme/ome::09-dermatology::05-hyperpigmentation
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::surgery::uworld::dorian
  - "source/ak-step2-v11:": 
  - theme/subjects::dermatology::09-miscellaneous-skin-disorders::actinic-keratosis
  - source/ak-step2-v11::original-decks::dorian::surg::uw"
type: flashcard
---

# Question
How can actinic keratosis be treated?   **Destruction in situ with cryotherapy Topical fluorouracil::2**   * Bonus: histological features & cancerous continuum?

---

# Answer
A small percentage of AKs progress to invasive SCC squamous cell carcinoma; therefore, frequent monitoring is necessary.  Histology: - keratinocyte atypia,  - hyperkeratosis, and  - parakeratosis.